Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 4 publications
Patient-reported outcomes in relapsed/refractory multiple myeloma treated with melflufen plus dexamethasone: analyses from the Phase II HORIZON study.
Journal: British journal of haematology
Published: August 04, 2021
Melflufen and Dexamethasone in Heavily Pretreated Relapsed and Refractory Multiple Myeloma.
Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Published: December 09, 2020
Simultaneous presentation of two distinct plasma cell neoplasms.
Journal: Proceedings (Baylor University. Medical Center)
Published: March 13, 2018
Haematological complete remission by ponatinib and bortezomib in a patient with relapsed, Ph⁺ pre-B acute lymphoblastic leukaemia.
Journal: BMJ case reports
Published: April 15, 2014
Showing 1-4 of 4
Last Updated: 09/26/2026